Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Accumulated Depreciation (2016 - 2022)

Historic Accumulated Depreciation for HUTCHMED (China) (HCM) over the last 9 years, with Q4 2022 value amounting to $36.9 million.

  • HUTCHMED (China)'s Accumulated Depreciation rose 1205.2% to $36.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $36.9 million, marking a year-over-year increase of 1205.2%. This contributed to the annual value of $36.9 million for FY2022, which is 1205.2% up from last year.
  • Latest data reveals that HUTCHMED (China) reported Accumulated Depreciation of $36.9 million as of Q4 2022, which was up 1205.2% from $32.9 million recorded in Q4 2021.
  • HUTCHMED (China)'s 5-year Accumulated Depreciation high stood at $36.9 million for Q4 2022, and its period low was $19.8 million during Q4 2018.
  • In the last 5 years, HUTCHMED (China)'s Accumulated Depreciation had a median value of $26.3 million in 2020 and averaged $27.8 million.
  • Its Accumulated Depreciation has fluctuated over the past 5 years, first skyrocketed by 2518.17% in 2021, then soared by 1205.2% in 2022.
  • HUTCHMED (China)'s Accumulated Depreciation (Quarter) stood at $19.8 million in 2018, then grew by 17.78% to $23.4 million in 2019, then increased by 12.54% to $26.3 million in 2020, then rose by 25.18% to $32.9 million in 2021, then increased by 12.05% to $36.9 million in 2022.
  • Its Accumulated Depreciation was $36.9 million in Q4 2022, compared to $32.9 million in Q4 2021 and $26.3 million in Q4 2020.